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Anaphylatoxins  C3a  and  C5a  are  important  modulators  for dendritic  cell  activation  and  function  in mice.
In order  to  verify  the signiﬁcance  of  these  observations  in  man,  we  have  investigated  the  functional
modulation  of  human  monocytes  derived  DCs by  C3a  and  C5a.  Here  we  report  that  engagement  of  C3aR
or C5aR  on human  monocytes  derived  DCs  (moDCs)  enhances  the  cell  activation  and  their  capacity  fornaphylatoxins
3a
5a
endritic cells
unctional modulation
 cell response
allostimulation.  In  addition,  we  show  that  intracellular  production  of  cAMP  is reduced  and  PI3K/AKT,
ERK  and  NF-B  signalling  is  increased  following  stimulation  with  C3a  or C5a,  identifying  intracellular
signalling  pathways  that could  convert  cell  surface  C3aR  and  C5aR  engagement  into  changes  in  moDC
functions.  Our  data  provide  evidence  that  human  DCs  are  equipped  to  react  to  C3a/C5a  and  undergo
phenotypic  change  as  well  as  functional  modulation.  Complement  offers  a potential  route  to  modulate
human  DC function  and  regulate  T cell  mediated  immunity.ntroduction
The small fragments (e.g. C3a and C5a) released during the
ourse of complement activation play an important role in inﬂam-
ation. They act on speciﬁc receptors (e.g. C3aR and C5aR)
xpressed on different types of cells (e.g. mast cells, endothelial
ells, and phagocytes) causing cell activation and degranulation,
nd histamine release, which in turn increase vascular permeabil-
ty, extravasation of serum proteins and migration of phagocytes,
hus contributing to local inﬂammation. Besides their traditional
oles in inﬂammatory responses, it has now become clear that ana-
hylatoxins (C3a, C5a) also play important roles in regulating the
daptive immune responses (reviewed by Peng et al. 2009a; Klos
t al. 2009). One important mechanism underlying this regulation
s that C3a/C5a acts on their receptors expressed on antigen pre-
enting cells such as dendritic cells, monocytes/macrophages to
odulate the cell activation and function, consequently regulating
ntigen speciﬁc T cell responses.
Recent studies in mouse have demonstrated that C3a and C5a
an regulate T cell responses through modulating DC activation and
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function. It has been shown that stimulation of C3aR with receptor
ligand (C3a) increased the capacity of murine bone morrow (BM)
DC for Ag presentation and enhanced its ability to stimulate the
allospeciﬁc T cell response. Conversely, in the absence of C3a–C3aR
interactions, due to absent expression of C3aR, DC function was
impaired, and manifested as a less activated phenotype, with
reduced capacity for Ag uptake/presentation and lowered ability
to stimulate Th1 responses in vitro and in vivo (Li et al. 2008; Peng
et al. 2008). Similar observations have being made on C5a, C5a
stimulation enhanced murine BMDC activation and its function in
allostimulation (Peng et al. 2009b). Conversely BMDCs from C5aR
deﬁcient mice had less-activated phenotype with lowered surface
expression of MHC  class II, CD86 and CD40, and consequently had
reduced capacity to stimulate allospeciﬁc T cells. In support for the
role for C5a in DC functional modulation, BMDCs from C5 deﬁcient
mice (which are unable to generate C5a) produced less IL-12 (a Th1
driving molecule) and expressed lower CD40 after BCG infection
compared with DCs from WT mice; BCG-primed C5 deﬁcient DCs
elicited defective Th1 responses, concurrent with an increased
growth of BCG in lungs (Moulton et al. 2007). These results provide
strong evidence that C3a and C5a can act directly on their receptors
expressed on murine DCs resulting in cell activation and functional
modulation, consequently up-regulating Th1 responses.
Open access under CC BY license. So far, most evidence for C3a/C5a acting on DCs comes from
the studies in mice. Such phenomenon has not been well docu-
mented in human DCs. A previous study on a single C3 deﬁcient
person has found that the in vitro development of immature den-
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ritic cells and their maturation capacity were greatly impaired,
ith decreased CD1a expression and IL-12p70 secretion ability,
uggesting that complement activation plays an important role
n DC differentiation and maturation, which is possibly through
he effect of complement effectors (e.g. C3a and C5a) (Ghannam
t al. 2008). Furthermore, several studies on human monocyte-
erived DCs (moDCs) have shown that DCs express a wide range
f complement components, receptors and regulators, including
3aR and C5aR (Weinmann et al. 2003; Li et al. 2011; Gutzmer
t al. 2004); C3a or C5a stimulation induces F-actin polymerisation
nd up-regulates the surface expression of CD54, CD83 and CD86
n DCs (Weinmann et al. 2003; Gutzmer et al. 2004), suggesting
hat DCs can detect and respond to C3a anf C5a stimulation. How-
ver, the functional signiﬁcance of these observations, in terms of
odulating DC function and regulating T cell responses is not well
eﬁned.
In the present study, we investigated the expression of sur-
ace molecules, cytokine proﬁle and function of human moDCs in
esponse to C3a or C5a stimulation. We  also explored the signalling
athways that are involved in C3a/C5a mediated DC modulation.
aterials and methods
eagents
Microbeads for CD14 were purchased from Miltenyi (Surry, UK).
M-CSF was purchased from Firstlink (Brierley Hill, UK). Recom-
inant human C5a was purchased from Sigma–Aldrich (Dorset,
K). Puriﬁed human C3a was purchased from Cortex Biochem (CA,
SA). [3H]-TdR and ECL Western Blotting Detection Reagents were
urchased from GE Healthcare UK Limited (Bucks, UK). Antibody
eagents used in signalling pathway studies were purchased from
ell Signalling Technology (Beverly, USA). Cytometric beads array
CBA) kit was purchased from BD Biosciences (Oxford, UK). The fol-
owing monoclonal anti-human antibodies were used for the detec-
ion of cell surface molecule and complement receptor expression
y ﬂow cytometry: FITC anti-HLA-DR (Sigma, St. Louis, USA), -CD40
BD Biosciences, Oxford, UK), -CD86 (Caltag Medsystem, Bucking-
am, UK); PE anti-C3aR, -C5aR (Biolegend, San Diego, USA).
amples
Human buffy coats were obtained from NBS-South Thames,
ondon, UK, which was approved by the local research ethics com-
ittee of Guy’s Hospital, London, UK.
reparation of human DCs
Monocyte-derived DCs were generated from peripheral blood
onocytes by treatment with GM-CSF and IL-4. PBMC were
solated from buffy coat preparations from healthy donors by
icoll-Hypaque gradient centrifugation, followed by anti-CD14
ead selection. The CD14 negative cell fraction was  used for T
ell isolation, as described below. CD14+ monocytes were cul-
ured in RPMI-10% FCS, 2 mM l-glutamine, and 100 U/ml penicillin
nd streptomycin in the presence of GM-CSF (20 ng/ml) and IL-4
20 ng/ml) at 37 ◦C in 5% CO2 atmosphere for 5 days. Cells were
urther cultured for 24 h with or without C3a or C5a at different
oncentrations, unless otherwise speciﬁed.
reparation of T cellsT cells were prepared from the CD14− fraction of human buffy
oats. CD4+ T cells were obtained by negative selection using anti-
D8, anti-CD33, anti-CD16, anti-CD19 and anti-CD56.y 217 (2012) 65– 73
RT-quantitative PCR
Real-time RT-quantitative PCR (RT-qPCR) was performed with
an MJ  Research PTC-200 Peltier Thermal Cycler and DyNAmoTM
HS SYBR® Green qPCR kit (MJ  BioWorks, Finland). PCR was set
up in low-proﬁle microplates containing 10 l of master mix,
1 l diluted cDNA (reﬂecting 0.1 g of total RNA), 5 pmol of
each 3′ and 5′ primer pair, either for each testing gene or
18s gene (the information for primer sequences are shown in
Supplementary table), in 20 l reaction volume. Ampliﬁcation was
performed according to manufacturer’s cycling protocol and done
in triplicate. Gene expression was  expressed as 2−(Ct), where
Ct is cycle threshold, (Ct) = un-stimulated DCs (Ct) − C3a
or C5a stimulated DCs (Ct); (Ct) = testing gene (Ct) − 18s
(Ct).
Measurement of intracellular cAMP
DCs (2 ×106) were seeded in 12 well plate and cells were incu-
bated with forskolin (5 nM)  for 30 min. The cells were further
incubated for 30 min in the presence or absence of C3a or C5a. The
treated cells were re-suspended cells in cell lysis buffer (R&D Sys-
tems, Europe Ltd, Abingdon, UK). Cell lysate was centrifuged for
10 min at 600 × g to remove cellular debris. The concentration of
cAMP was  determined in each sample using a ParameterTM cAMP
assay kit (R&D Systems) according to the manufacturer’s instruc-
tions.
Measurement of cytokine production
IL-12 production was  measured in supernatants from C3a or
C5a treated DCs in the presence of CD40L-transfected L cells by
sandwich ELISA. The puriﬁed and biotinylated antibody pairs were
purchased from BD Biosciences, UK. The production of IL-6, and
TNF- was  measured in the supernatants of DC cultures, and IFN-
, TNF- and IL-17A were measured in the supernatants of DC/T
cell co-cultures by CBA assays.
Analysis of DC allostimulatory capacity in vitro
To assess the stimulatory capacity of DCs, irradiated DCs
(1 × 104 per well) were co-cultured with puriﬁed allogeneic CD4+
T cells (3 × 104/well). After 5 days, cell cultures were pulsed with
1 Ci/well [3H]-TdR, and the proliferation was measured as [3H]-
TdR incorporation after 20 h incubation.
Western blot analysis
6 day DCs (2 × 106) were stimulated with C3a or C5a for up to
30 min. Cells were washed and lysed in 200 l of lysis buffer (Per-
bio Science, Northumberland, UK). Prior to analysis, lysates were
homogenized with an ultrasonic cell disruptor and cleared by cen-
trifugation (20 min, 15,000 × g at 4 ◦C). 10 l extract (corresponding
to 1 ×105 cells) per lane was separated onto 12% SDS PAGE followed
by electro blotting. Blocking was performed in Tris-buffered saline
(TBS) containing 5% non-fat milk power for 1 h. Membranes were
incubated with the following primary antibodies in TBS containing
5% BSA and 0.1% Tween 20 overnight at 4 ◦C: anti-phospho-ERK1/2,
-AKT and -IB antibodies and anti-ERK1/2, -AKT and -IB anti-
bodies. Immunoblots were developed using ECL Western Blotting
Detection Reagents. The relative amounts of phosphorylated pro-
teins were evaluated through densitometry using Image J software
(NIH Image).
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henotypic changes of DCs in response to C3a or C5a stimulation
One of the most important functions for DC is the stimulation
f T cells, and this largely depends on their state of activation, we
nitially investigated the phenotypic changes of human moDCs in
esponses to C3a or C5a stimulation. We  treated moDCs with either
3a or C5a at different concentrations for 24 h, and analyzed the
ene and cell surface expression of MHC  class II and co-stimulatory
olecules by RT-PCR and ﬂow cytometry. We  found that gene
xpression of HLA-DR, CD86 and CD40 in DCs was  increased by
3a or C5a stimulation, particularly at relatively low concentra-
ions (C3a: 5–20 nM,  C5a: 2.5–10 nM). The gene expression was
ess affected at the high concentration of C3a (100 nM)  or C5a
50 nM)  (Fig. 1A). Consistent with the gene expression, cell surface
xpression of HLA-DR, CD86 and CD40 was increased by C3a or C5a
timulation (Fig. 1B). These results indicate that DCs exhibit a more
ctivated phenotype following C3a or C5a stimulation at certain
oncentrations.
ffects of C3a or C5a stimulation on inﬂammatory cytokine
roduction by DCs
Having shown that both C3a and C5a have effects on DC acti-
ation phenotype, we next examined the effects of C3a or C5a
ig. 1. Effects of C3a and C5a stimulation on the expression of HLA-DR, CD86 and CD40 b
hen  used for analyzing the gene expression by RT-PCR and cell surface expression by ﬂo
s  means ± SEM of 3 individual experiments. Statistical signiﬁcance calculated using on
hows  representative histogram plot overlay of the un-stimulated DCs (gray and black pro
uorescence intensity (MFI) of each surface molecule. Data are presented as percentage 
xperiments. Statistical signiﬁcance calculated using Student’s t-test (*p < 0.05, **p < 0.01,y 217 (2012) 65– 73 67
stimulation on inﬂammatory cytokine production by DCs. We
treated moDCs with either C3a or C5a at different concentrations
for 24 h, and analyzed the gene expression and cytokine secretion
of IL-6 and TNF- by the cells. We  found that gene expression of IL-6
and TNF- was  increased by C3a or C5a stimulation in a dose depen-
dent manner (at 0–20 nM for C3a and 0–10 nM for C5a), though the
high dose of C3a (100 nM)  had no effect on both IL-6 and TNF-
gene expression (Fig. 2A and B). In addition to the changes of gene
expression, protein levels of IL-6 and TNF- in 24-h supernatants of
DCs were also increased in the presence of C3a or C5a, though the
effect of C3a on TNF- was  relatively small (Fig. 2C and D).  We  also
examined the effect of C3a and C5a on CD40L mediated IL-12 pro-
duction by DCs and found that C3a or C5a pretreated DCs produced
signiﬁcantly higher amount of IL-12 compared with untreated DCs
(Fig. 2E). Together, these results indicate that DCs have increased
ability to produce inﬂammatory cytokines in response to C3a/C5a
stimulation. It also suggests that following the C3a/C5a stimulation,
DCs become more potent to stimulate Th1 responses, as a result of
up-regulated IL-12 production.
Effects of C3a and C5a stimulation on the expression of C3aR and
C5aR by moDCsOur previous study with moDCs has shown that gene expression
of C3aR and C5aR can be regulated by human serum which contains
complement, suggesting that complement activation itself can lead
y moDCs. DCs were treated with C3a or C5a at different concentrations for 24 h and
w cytometry. (A) Gene expression of HLA-DR, CD86 and CD40. Data are presented
e-way ANOVA. (B) Surface expression of HLA-DR, CD86 and CD40. The left panel
ﬁles) and C3a or C5a stimulated DCs (open proﬁles). The right panel displays mean
of MFI of un-stimulated DCs, set as 100%. Data are means ± SEM of 3 independent
 ***p < 0.005) compared with un-stimulated DCs.
68 K. Li et al. / Immunobiology 217 (2012) 65– 73
0.5
1.0
1.5
2.0
*
**
ns
TN
F-
α
 m
R
N
A
1.0
1.5
2.0
2.5 p=0.002
0.5
1.0
1.5
2.0
*
***
ns
IL
-6
 m
R
N
A
0.5
1.0
1.5
2.0
p=0.003
0 5  20 100
0.0
C3a (nM)
(A
rb
ita
ry
 u
ni
ts
)
 0 2.5 10 50
0.0
0.5
C5a (nM)
0 5  20 100
0.0
C3a (nM)
(A
rb
ita
ry
 u
ni
ts
)
0 2.5 10 50
0.0
C5a (nM)
1.0
1.5
2.0
L-
6 
(n
g/
m
l)
1.0
1.5
2.0
20
30
40
α
 (p
g/
m
l)
20
30
40
50
0 5  20 100
0.0
0.5
C3a (nM)
IL
0 2.5 10 50
0.0
0.5
C5a (nM)
0 5  20 100
0
10
C3a (nM)
TN
F-
0 2.5 10 50
0
10
C5a (nM)
200
300
400
100
150
200
0 5 25 50
0
100
C5a (nM)
0 5 20 100
0
50
C3a (nM)
IL
-1
2 
(p
g/
m
l)
A B
DC
E
Fig. 2. Effects of C3a and C5a stimulation on cytokine production by moDCs. DCs were treated with C3a or C5a at different concentrations for 24 h. The cells and the
supernatants were used for analyzing the gene expression and cytokine secretion. (A and B) Gene expression of IL-6 and TNF-. Data are presented as means ± SEM of 3
individual experiments. Student’s t-test or ANOVA was used where appropriate to determine signiﬁcant differences between un-stimulated and C3a or C5a stimulated DCs
(*p  < 0.05, **p < 0.01, ***p < 0.005). (C and D) Secretion of IL-6 and TNF-. (E) Secretion of IL-12. Data in C–E are presented as means ± SEM of duplicate samples and are
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o auto-regulation of C3aR and C5aR expression. To investigate the
ossibility that C3a/C5a could auto-regulate the expression of C3aR
nd C5aR by DCs, we treated moDCs with either C3a or C5a at differ-
nt concentrations for 24 h, and analyzed the gene and cell surface
xpression of C3aR and C5aR by RT-PCR and ﬂow cytometry. We
ound that the gene expression of both receptors was  up-regulated
y lower doses of C3a (5 and 20 nM)  and C5a (2.5 and 10 nM),
his was consistent with the observations on other molecules (i.e.
HC class II and co-stimulatory molecules, IL-6, TNF-) (Fig. 3A).
nterestingly, however, we found that cell surface expression of
oth receptors was reduced following the stimulation with its spe-
iﬁc ligand in a dose dependent manner (C3a: 0–100 nM,  C5a:
–50 nM)  (Fig. 3B). Thus, C3a or C5a stimulation up-regulated the
ene expression of both C3aR and C5aR, but down regulated the cell
urface expression of its own receptor in moDCs. In addition, C5a
timulation also caused a small reduction in cell surface expression
f C3aR, but C3a stimulation had no effect on surface expression of
5aR (Fig. 3B).Effects of C3a and C5a on allo-stimulatory ability of moDCs
So far we have demonstrated the effects of C3a and C5a on moDC
activation phenotype and inﬂammatory cytokine production; we
next investigated whether C3a and C5a can modulate moDC func-
tion in T cell stimulation. We  pre-treated moDCs with either C3a
or C5a at different concentrations for 24 h, and then co-cultured
them with puriﬁed allogeneic CD4 T cells. The cell proliferative
response and inﬂammatory cytokine production were carried out
after 3 and 5 days of co-culture, respectively. We  found that there
were higher proliferative responses when T cells were co-cultured
with DCs pre-treated with C3a or C5a compared with those co-
cultured with untreated DCs (Fig. 4A). Furthermore, the levels of
several inﬂammatory cytokines including IFN-, IL-17A and TNF-
 were increased in the supernatants of co-cultures of T cells
and C3a or C5a pre-treated DCs, compared with co-cultures of T
cells and untreated DCs (Fig. 4B). The enhancement of proliferative
responses and inﬂammatory cytokine production appear to occur
K. Li et al. / Immunobiology 217 (2012) 65– 73 69
Fig. 3. Effects of C3a and C5a stimulation on the expression of C3aR and C5aR by moDCs. DCs were treated with C3a or C5a at different concentrations for 24 h and then
used  for analyzing the gene by RT-PCR and cell surface expression of C3aR and C5aR by ﬂow cytometry. (A) Gene expression of C3aR and C5aR. (B) Surface expression of
C3aR  and C5aR. Histogram plot overlay of the un-stimulated DCs (gray and black proﬁles) and C3a or C5a stimulated DCs (open proﬁles) are shown in the left panel and
the  quantiﬁcation of MFI is shown in the right panel. Data in A and B are presented as means ± SEM of 3 individual experiments. Student’s t-test or ANOVA was used where
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dppropriate to determine signiﬁcant differences between un-stimulated and C3a or
n a dose-dependent manner for C3a (0–20 nM)  and C5a (0–10 nM).
 relatively high dose of C5a (50 nM)  has less effect or even adverse
ffect in some cases. Together, these results suggest that engage-
ent C3aR or C5aR on DCs has a positive impact on DC activation
nd its function in T cell stimulation.
3a or C5a stimulation mediates inhibition of cAMP production in
oDCs
Having demonstrated roles for C3aR and C5aR in regulating DC
ctivation and function in T cell stimulation, we next examined the
ntracellular signalling pathways by which C3aR and C5aR could
licit such effects. C3aR and C5aR are G-protein coupled receptors
GPCRs). GPCRs can activate multiple intracellular signalling path-
ays, among which cAMP pathway is one of the key pathways.
AMP is a cyclic nucleotide that functions as an intracellular second
essenger which regulates a wide range of important cellular pro-
esses. It has been shown that elevated cAMP has a negative impact
n DC activation and function (Galgani et al. 2004; Kambayashi et
l. 2001). We  have previously shown that ligation of C3aR or C5aR
n murine BMDCs induced inhibition of cAMP production, conse-
uently permitting DC activation (Li et al. 2008; Peng et al. 2009b).
herefore, we investigated whether the same is true for human
oDCs. We  stimulated moDCs with C3a or C5a at different concen-
rations and measured the cAMP in the cell lysate. We  found that
3a or C5a stimulation reduced the cAMP levels in moDCs in a dose
ependent manner (Fig. 5). Thus, our results, in consistence withtimulated DCs (*p < 0.05; **p < 0.01, ***p < 0.005, ns, not signiﬁcant).
murine BMDCs, demonstrate that engagement of C3aR or C5aR on
human moDCs induces inhibition of cAMP production, which con-
sequently may  release the DC from the inhibitory effects of cAMP
and thereby up-regulate DC activation and its functions.
C3a or C5a stimulation activates PI3K, MAPKs and NF-B
signalling in moDCs
Besides cAMP, we  investigated several other important sig-
nalling pathways (PI3K, MAPKs and NF-B) which are also known to
be activated downstream of GPCR ligation (Marinissen and Gutkind
2001), to determine their role in converting C3aR and C5aR sig-
nalling into DC functional change. We  examined phosphorylation of
IB (an indicator of NF-B activation), AKT (a downstream effector
of PI3K) and ERK1/2 (a member of MAPKs) in response to C3a or C5a
stimulation. We found that phosphorylation of AKT (p-AKT), ERK
(p-ERK) and IB (p-IB) was  detected in both un-stimulated and
C3a or C5a stimulated moDCs. Following C3a (20 nM)  stimulation,
the amount of p-AKT, p-ERK and p-IB was increased and peaked
at 10, 5 and 30 min, respectively (Fig. 6A–C). Following C5a (10 nM)
stimulation, p-AKT, p-ERK and p-IB were similarly increased,
except that p-AKT peaked (at 5 min) more rapidly than with C3a
stimulation (Fig. 6D–F). These results indicate that engagement of
C3aR or C5aR on moDCs can induce rapid activation of PI3K, ERK
and NF-B pathways, which could confer C3a or C5a mediated up-
regulation of DC activation and functions.
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Fig. 4. Effects of C3a and C5a on allo-stimulatory ability of moDCs. DCs were treated with C3a or C5a at different concentrations for 24 h and then co-cultured with puriﬁed
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iscussion
The present study extends our previous ﬁndings in murine
MDCs to human moDCs by showing that the cell activation,
nﬂammatory cytokine production and allo-stimulatory ability of
oDCs were up-regulated by C3a or C5a at certain concentrations.
ince C3a or C5a has similar effects in mouse and human DCs, this
uggests a well conserved biological mechanism for strengthening
nd directing the adaptive immune response.
Using C3a or C5a to stimulate (relative immature) day 5 moDCs,
e demonstrate that, C3aR or C5aR engagement up-regulates DC
ctivation which is evident by increased expression of MHC  class II
nd co-stimulatory molecules and inﬂammatory cytokine produc-
ion (i.e. IL-12, IL-6, TNF-). Moreover, C3aR or C5aR engagement
p-regulates DC function in T cell stimulation which was supported
y enhanced proliferative responses and Th1 cytokine (IFN-, TNF-
) production upon allostimulation. As direct allostimulation is
argely dependent on MHC  and co-stimulatory molecule expres-
ion on donor APCs, and in view of the fact IL-12 released by DCs
an act as a T cell stimulating factor, C3a or C5a mediated modula-
ion of these molecules could confer an enhanced allo-stimulatory
apacity of DCs. Furthermore, our data show that in addition to Th1
ytokine production, Th17A was also elevated in the supernatants
hen T cells were co-cultured with C3a or C5a treated DCs com-
ared with untreated DCs, such elevation could be attributed to
nhanced IL-6 production by DCs following C3a or C5a stimulation
Acosta-Rodriguez et al. 2007). These data suggest that C3a and C5a
ave positive effect on both Th1 and Th17 responses in our system.
owever, given that the amount of IL-17A detected in our assays
as relatively small compared with that of IFN-, and the secre-
ion of IL-12 (a driver of Th1 responses) by DCs was signiﬁcantly
ncreased following C3a or C5a stimulation, it would suggest that
odulation of allo-stimulatory ability of DCs by C3a or C5a mainly
nvolves the regulation of Th1 responses.
We  have used different ranges of C3a (0–100 nM)  and C5a
0–50 nM)  to assess their effects on DC activation and function. The
hoice of the higher dose range of C3a than that of C5a in our study
as based on the fact that serum concentrations of C3a are higherhan those of C5a under both normal and pathological conditions
Bengtson and Heideman 1988). Our data show that 0–20 nM of C3a
r 0–10 nM of C5a was a concentration range within which moDC’s
ctivation, inﬂammatory cytokine production and allo-stimulatoryta are presented as means ± SEM of duplicate samples and are representative of 3
ability were up-regulated. In some cases of our study, the 100 nM
C3a or 50 nM C5a had less effect or even inhibitory effect on DC
activation and function. Therefore, the regulation of DC function by
C3a/C5a seems to depend on C3a/C5a concentrations which cells
were exposed to; lower concentrations could have positive impact
on cell activation and function, while higher concentrations could
have negative impact on cells. In addition to the concentrations,
C3a/C5a mediated DC regulation may  also depend on the activa-
tion state of the cells. We  have noted that more mature DCs, when
exposed to C3a or C5a (even at lower doses), can either do not
respond to the stimulation or have reduced cell activation and allo-
stimulatory ability (our unpublished observation). Together, these
observations highlight the complexities of the role for C3a and C5a
in DC regulation, which would likely depend on the concentrations
of C3a/C5a and the activation state of the DCs.
In this study we  have investigated the effects of C3a or C5a on the
expression of its own  receptor by moDCs. Interestingly, we found
that the cell surface expression was  not correlated with the gene
expression in response to C3a or C5a stimulation. The reasons for
this were not clear and need to be further studied. We can postulate
that the increased C3aR and C5aR gene expression could reﬂect the
cell activation caused by either C3aR or C5aR engagement, while
the reduced surface expression of the receptors could be explained
by a phenomenon of GPCR called ligand induced receptor inter-
nalisation (Pierce et al. 2002). It is possible that DCs have a self
control mechanism to prevent themselves from over activation by
C3a or C5a, particularly under inﬂammatory/pathological condi-
tions, through reducing cell surface expression of its own  receptor
(C3aR, C5aR). C5a stimulation also caused a small reduction in cell
surface expression of C3aR, suggesting that C5a may  involve C3aR
internalisation.
Another important ﬁnding in this study is the identiﬁcation
of several intracellular signalling pathways by which C3a or C5a
could modulate moDC function. First is intracellular cAMP, a potent
negative regulator of inﬂammatory cytokines. Our previous stud-
ies in mouse have shown that elevation of intracellular cAMP in
DCs is associated with lowered surface expression of MHC  class
II and co-stimulatory molecules, and decreased pro-inﬂammatory
cytokine (i.e. IFN-, TNF-, IL-12) production (Li et al. 2008; Peng
et al. 2009b).  In this study we  extended our observations to human
moDCs. Our results show that C3a or C5a stimulation signiﬁcantly
reduced intracellular levels of cAMP, and increased surface expres-
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Fig. 6. C3a or C5a stimulation activates PI3K, MAPKs and NF-B signalling in moDCs. DCs were stimulated with an optimized dose of C3a (20 nM)  (A–C) or C5a (10 nM) (D–F)
f  of AKT
i  corre
a ure. A
s
t
a
t
s
i
w
e
p
t
t
r
r
o
c
a
t
a
eor  indicated time periods. The cell lysates ware used for analyzing phosphorylation
ncubating membrane with appropriate total antibody and the bottom row of bands
mounts of p-AKT, p-ERK1/2 and p-IB are shown in the lower panel of the each ﬁg
ion of MHC  class II and B7.2 and IL-12 expression, demonstrating
hat engagement of C3aR/C5aR on DCs leading to inhibition of the
denylate cyclase pathway is important for modulating DC activa-
ion and function. In addition to the stimulation of conventional
econd-messenger-generating systems, such as cAMP, GPCRs also
nvolve a complicated network of intracellular signalling path-
ays (e.g. PI3K, MAPKs and NF-B). PI3K has been linked to an
xtraordinarily diverse group of cellular functions (e.g. cell growth,
roliferation, differentiation, motility, survival and intracellular
rafﬁcking). MAPK/ERK is associated with cell division in many
ypes of cells. NF-B is a key transcription factor responsible for
egulation of numerous genes during inﬂammation and immune
esponses. Our previous studies in DCs have shown that activation
f PI3K, ERK1/2 and NF-B mediates positive regulation of several
ellular processes including antigen uptake, antigen presentation
nd pro-inﬂammatory cytokine production. In this study we show
hat engagement of C3aR/C5aR mediates the activation of PI3K, ERK
nd NF-B pathways in human DCs, suggesting that C3a/C5a can
xert its functions through C3aR/C5aR mediated signalling path-, ERK1/2, and IB by Western blot. In each blot the top row of bands corresponds to
sponds to incubating membrane with appropriate anti phospho-antibody. Relative
 representative of 3 independent experiments is shown.
ways. Thus our ﬁndings provide evidence that C3a/C5a can directly
act on human DCs through interaction with their receptors on DCs,
which induce a network of intracellular signalling pathways and
subsequently modulate DC function.
In conclusion, in this study we demonstrate that human imma-
ture moDCs, in response to C3a or C5a stimulation, undergo
phenotypic activation and functional modulation. Although some
of the DC responses to C3a or C5a that we  presented in this study
are not extraordinarily large, all the responses were consistently
observed in least 3 independent experiments and occurred in a
dose dependent manner. We  also show that engagement of C3aR
or C5aR results in inhibition of cAMP pathway and activation of
PI3K, MAPKs and NF-B signalling pathways which could con-
fer the up-regulated DC activation and function. The behavioural
similarities of human and mouse DCs in response to comple-
ment activation products C3a/C5a provide a necessary translational
step and strengthen the rationale for exploring complement based
strategies for the manipulation of human immune mediated
disease.
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